Lucid Diagnostics, Inc. (LUCD)
0.6273
-0.01
(-1.18%)
USD |
NASDAQ |
Oct 02, 16:00
0.6349
+0.01
(+1.21%)
After-Hours: 20:00
Lucid Diagnostics Debt to Equity Ratio : 2.280 for June 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.280 |
| March 31, 2026 | 6.701 |
| December 31, 2025 | 2.361 |
| September 30, 2025 | 0.9419 |
| June 30, 2025 | 3.505 |
| March 31, 2025 | -6.559 |
| December 31, 2024 | 3.942 |
| September 30, 2024 | 2.062 |
| June 30, 2024 | 0.891 |
| March 31, 2024 | 1.192 |
| December 31, 2023 | -6.601 |
| September 30, 2023 | 6.292 |
| June 30, 2023 | 0.8918 |
| March 31, 2023 | 0.5532 |
| Date | Value |
|---|---|
| December 31, 2022 | 0.0867 |
| September 30, 2022 | 0.0727 |
| June 30, 2022 | 0.0574 |
| March 31, 2022 | 0.0478 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | -0.9281 |
| June 30, 2021 | -1.123 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| IDEXX Laboratories, Inc. | 0.6797 |
| Neogen Corp. | 0.388 |
| QuidelOrtho Corp. | 1.733 |
| Aspira Women's Health, Inc. | -0.4279 |
| VolitionRX Ltd. | -0.3547 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 38.95M |
| Total Liabilities (Quarterly) | 28.02M |
| Shareholders Equity (Quarterly) | 10.93M |
| Current Ratio | 1.331 |
| Net Debt Paydown Yield | 1.02% |